Early prediction of success or failure of treatment with second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia

BACKGROUND: Second-generation tyrosine kinase inhibitors induce cytogenetic responses in approximately 50% of patients with chronic myeloid leukemia in chronic phase in whom imatinib treatment has failed. However, it has not yet been established which of the patients in whom imatinib treatment fails...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Milojkovic, Dragana, Nicholson, Emma, Apperley, Jane F., Holyoake, Tessa L., Shepherd, Pat, Drummond, Mark W., Szydlo, Richard, Bua, Marco, Foroni, Letizia, Reid, Alistair, Khorashad, Jamshid S., de Lavallade, Hugues, Rezvani, Katy, Paliompeis, Christos, Goldman, John M., Marin, David
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2010
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2817024/
https://ncbi.nlm.nih.gov/pubmed/19833633
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2009.012781
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados